Isabelle Isnardi, PhD

Novartis
Gueberschwihr, France

B cell immunologist.

Presentation(s):

• 2342: Modulation of B Cell and Interferon Pathways by Ianalumab in Patients with Systemic Lupus Erythematosus: Findings from a Phase 2 Clinical Trial

  Tuesday, November 14, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.